The current P/E ratio for Mimedx Group stock as of Mar 19, 2025 is 27.9. This is calculated based on the TTM EPS of $0.29 and the stock price of $8.09 per share. The PE ratio has increased by 64% from its last 4 quarters average of 17.0.
The average historical PE ratio of Mimedx Group for the last ten years is 38.84. The current price-to-earnings ratio of 27.9 is 28% less than the historical average. Analyzing the last ten years, MDXG's PE ratio reached its highest point in the Mar 2015 quarter at 94.55, when the price was $10.4 and the EPS was $0.11. The lowest point was recorded in the Sep 2024 quarter, when it reached 9.38 with a price of $5.91 and an EPS of $0.63.
Maximum annual increase: 140.74% in 2016
Maximum annual decrease: -82.59% in 2015
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 33.17 | 51.25% | $9.62 | $0.29 |
2023 | 21.93 | N/A | $8.77 | $0.4 |
2022 | N/A | N/A | $2.78 | -$0.33 |
2021 | N/A | N/A | $6.04 | -$0.15 |
2020 | N/A | N/A | $9.08 | -$0.77 |
2019 | N/A | N/A | $7.58 | -$0.24 |
2018 | N/A | N/A | $1.79 | -$0.28 |
2017 | 20.67 | -74.34% | $12.61 | $0.61 |
2016 | 80.55 | 140.74% | $8.86 | $0.11 |
2015 | 33.46 | -82.59% | $9.37 | $0.28 |
2014 | 192.17 | N/A | $11.53 | $0.06 |
2013 | N/A | N/A | $8.74 | -$0.04 |
2012 | N/A | N/A | $3.84 | -$0.09 |
2011 | N/A | N/A | $1.13 | -$0.14 |
2010 | N/A | N/A | $1.35 | -$0.19 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 33.17 | 253.62% | $9.62 | $0.29 |
Sep 2024 | 9.38 | -13.39% | $5.91 | $0.63 |
Jun 2024 | 10.83 | -26.87% | $6.93 | $0.64 |
Mar 2024 | 14.81 | -32.47% | $7.7 | $0.52 |
Dec 2023 | 21.93 | N/A | $8.77 | $0.4 |
Sep 2023 | N/A | N/A | $7.29 | -$0.02 |
Jun 2023 | N/A | N/A | $6.61 | -$0.17 |
Mar 2023 | N/A | N/A | $3.41 | -$0.28 |
Dec 2022 | N/A | N/A | $2.78 | -$0.33 |
Sep 2022 | N/A | N/A | $2.87 | -$0.31 |
Jun 2022 | N/A | N/A | $3.47 | -$0.26 |
Mar 2022 | N/A | N/A | $4.71 | -$0.18 |
Dec 2021 | N/A | N/A | $6.04 | -$0.15 |
Sep 2021 | N/A | N/A | $6.06 | -$0.33 |
Jun 2021 | N/A | N/A | $12.51 | -$0.77 |
The current PE ratio of MDXG is above its 3 and 5-year averages, but it is under its 10-year average.
When compared to its peers STE and TFX, MDXG's PE ratio is lower, but it is higher than MDT's.
Stock name | PE ratio | Market cap |
---|---|---|
MDT Medtronic plc | 27.54 | $116.9B |
MDXG Mimedx Group Inc | 27.62 | $1.18B |
STE STERIS plc | 47.45 | $22.1B |
TFX Teleflex Inc | 92.82 | $6.41B |
ATEC Alphatec Holdings Inc | N/A | $1.44B |
The price to earnings ratio for MDXG stock as of Mar 19, 2025, stands at 27.9.
The 3-year average PE ratio for MDXG stock is 18.02.
The 5-year average PE ratio for MDXG stock is 18.02.
The highest quarterly PE ratio in the last ten years has been 94.55 and it was in the Mar 2015 quarter.
The current PE ratio of MDXG is 28% lower than the 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Mar 19, 2025), Mimedx Group's share price is $8.09. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.29. Therefore, Mimedx Group's price to earnings ratio for today is 27.9. PE RATIO(27.9) = STOCK PRICE($8.09) / TTM EPS($0.29)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.